HF
BPMC

HRT Financial’s Blueprint Medicines BPMC Stock Holding History

HRT Financial’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-69,916
Closed -$8.96M – 2891
2025
Q2 		$8.96M Buy
+69,916
New +$7.26M 0.04% 343
2025
Q1 		– Sell
-5,996
Closed -$522K – 2566
2024
Q4 		$522K Sell
5,996
-11,089
-65% -$1.02M ﹤0.01% 1415
2024
Q3 		$1.58M Buy
+17,085
New +$1.7M 0.01% 991
2024
Q2 		– Sell
-11,420
Closed -$1.08M – 2262
2024
Q1 		$1.08M Buy
11,420
+924
+9% +$79.2K 0.01% 847
2023
Q4 		$968K Buy
+10,496
New +$680K 0.01% 999
2022
Q4 		– Sell
-47,641
Closed -$3.14M – 2496
2022
Q3 		$3.14M Buy
+47,641
New +$3.06M 0.03% 440
2021
Q4 		– Sell
-3,090
Closed -$317K – 3225
2021
Q3 		$317K Buy
+3,090
New +$288K ﹤0.01% 2365
2019
Q2 		– Sell
-5,149
Closed -$412K – 752
2019
Q1 		$412K Buy
+5,149
New +$380K 0.06% 218

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's BPMC Position: Q3 2025 in Review

HRT Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 69,916 shares — an estimated $8.96M sold.

HRT Financial first reported a position in BPMC in Q1 2019 and held it in 8 quarters. The position peaked at $8.96M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • HRT Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 69,916 Blueprint Medicines shares in Q3 2025, an estimated $8.96M.
  • HRT Financial first reported a position in Blueprint Medicines in Q1 2019 and held it in 8 quarters.
  • HRT Financial's Blueprint Medicines position peaked at $8.96M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.